Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiRNA-Seq of human ZR75.1 cells expressing or not ER-beta in absence of estrogen stimuli

ABSTRACT: We performed microRNA sequencing (miRNA-seq) according to Illumina sequencing protocols. Total RNA extracted from ZR75.1 cells expressing or not human ER-beta in absence of estrogen stimuli was subjected to size selection library preparation and retrotranscribed. Obtained DNA was sequenced with the Illumina HiSeq 1500 sequencer .

ORGANISM(S): Homo sapiens

SUBMITTER: De Filippo Maria Rosaria

PROVIDER: S-ECPF-MTAB-2069 | biostudies-other |

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

miRNA-Seq of human MCF-7 cells expressing ER-beta in absence of estrogen stimuli

Project description: Not available

| S-ECPF-MTAB-2085 | biostudies-other

miRNA-Seq of human MCF-7 cells expressing or not ER-beta in absence of estrogen stimuli

Project description: Not available

| S-ECPF-MTAB-1495 | biostudies-other

Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.

Project description: Not available

| S-EPMC1552044 | biostudies-literature

ChIP-Seq of human MCF-7 cells with ER-alpha and ER-beta anitbodies following estrogen treatment

Project description:We performed chromatin immunoprecipitation (ChIP) with overnight with antibodies against the C-terminus (HC-20, from Santa Cruz Biotechnology, Europe) or the N-terminus (anti-Estrogen Receptor 18-32, from SigmaAldrich, Italy) of human ER-alpha with or without estrogen treatment for 45 minutes on TAP-ER-beta cells, and the immunoprecipitated DNA was sequenced with the Illumina/Solexa Genome Analyzer. (Note: Raw data files not provided by submitter)

2010-12-01 | E-MTAB-345 | biostudies-arrayexpress

Identification of the ER-beta cistrome in ER-beta expressing MDA-MB-231 cells [ChIP-seq]

Project description:We have utilized ChIPseq to identify the ER-beta cistrome in ER-beta expressing MDA-MB-231 triple negative breast cancer cells. ER-beta has been identified as a tumor suppressor in breast cancer and recent reports have demonstrated that ER-beta protein is detectable at moderate to high levels in approximately 30% of triple negative breast tumors. Increased expression of ER-beta in triple negative breast cancer has also been reported to be associated with improved recurrence-free survival. Treatment of ER-beta expressing triple negative breast cancer cells with estrogen, or the ER-beta selective agonist, LY500307, results in decreased cell proliferation, invasion and migration. To begin to identify the molecular mechanisms by which ER-beta elicits tumor suppressive effects in triple negative breast cancer, we performed ChIPseq studies and identified the genome-wide binding sites for ER-beta following exposure to 1nM estrogen or 10nM LY500307 for 3 hours. Over 28,000 and 10,000 unique ER-beta binding sites were identifed in response to these two ligands respectively. The top transcription factor motifs identified under both treatment conditions were estrogen response elements and AP1 response elements. The majority of ER-beta binding sites were found at enhancer regions located within introns or intergenic chromatin regions followed by gene promoters.

2018-08-23 | GSE108979 | GEO

Secondary Analysis of Human Bulk RNA-Seq Dataset Suggests Potential Mechanisms for Letrozole Resistance in Estrogen-Positive (ER+) Breast Cancer.

Project description: Not available

| S-EPMC11275280 | biostudies-literature

A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen.

Project description: Not available

| S-EPMC3383391 | biostudies-literature

Estrogen-regulated miRNA-27b is altered by bisphenol A in human endometrial stromal cells.

Project description: Not available

| S-EPMC6215928 | biostudies-literature

miRNA expression profile between ER-beta- and ER-beta+ breast tumors.

Project description:FFPE tissues samples were cut in 5-µm-thick sections on a microtome with a disposable blade. RNA was extracted either from three or eight sequential sections using miRNeasy FFPE Kit (QIAGEN), following the steps described in the manufacturers protocol. RNA extracted from same biological samples and different numbers of sections were pooled. Total RNA was fluorescently labelled, amplified in triplicate, to be then pooled, for hybridization. Each pool, were hybridized for 18 hours on Illumina v2 MicroRNA Expression BeadChips, and after scanning, the intensity files were analized.

2011-10-14 | E-TABM-1054 | biostudies-arrayexpress

Bioluminescent reporter assay for monitoring ER stress in human beta cells.

Project description: Not available

| S-EPMC6288136 | biostudies-literature